We describe a muftianalyte assay system for patient-side use comprising single-use plastic cartridges and a small monitor. Hemoglobin, glucose, and cholesterol can be simultaneously measured in 3 mm in an unmeasured volume of blood. The sample is drawn by capillary action into four channels for delivery to assay-specific stacks containing a set of closely apposed layers. The distal layer is a membrane that acts as the optical surface for reflectance optics. and other laboratory costs are included.
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We describe a muftianalyte assay system for patient-side use comprising single-use plastic cartridges and a small monitor. Hemoglobin, glucose, and cholesterol can be simultaneously measured in 3 mm in an unmeasured volume of blood. The sample is drawn by capillary action into four channels for delivery to assay-specific stacks containing a set of closely apposed layers. The distal layer is a membrane that acts as the optical surface for reflectance optics. For glucose and cholesterol assays, erythrocytes are removed by a fibrous filter layer and oxidase-peroxidase chemical reactions contained in the optical membrane generate a colored product. For hemoglobin measurement, blood is lysed by detergent contained in a porous disk. The amount of color reaching the optical membrane is measured by fiber optics. To ensure fail-safe operation, sensors verify sample sufficiency and degree of hemolysis. The assays perform comparably with laboratory methods.
AdditIonal Keyphrues User-accessible features include a card reader that imports lot-specific calibration information, with a slot in the monitor's top surface through which magnetically coded cards are passed; a liquid-crystal display (20 characters x 4 lines) that presents messages, user instructions, prompts, and results; a toggle switch for selecting display options from a menu including language, units, date, and time; and a cartridge-insertion mechanism with a horizontal slot on the front of the monitor; the cartridge is positioned so that the sample application site is easily accessible. The distance from the application site to the monitor surface is such that direct application from a finger stick is straightforward.
Monitor operation is controlled by a 16-bit microprocessor.The monitor has a five-channel reflectance optical system. The light source is an array of light-emitting diodes (LEDs) with emission maxima centered at 585, 637, 730, and 940 nm. Light from the array is transmitted by optical fibers into an optical-mixing device and then split into six fibers to illuminate an optical reference and five sites on the assay cartridge where the assay reactions occur. Because finger-stick samples are small and used for several assays, the volume of sample available for each assay is very small. The small diameter of the optical fibers permits satisfactory illumination of correspondingly small reaction areas. Light reflected from the optical surface of the assay site is collected by a set of fibers for transmission to detectors. Thermal equilibrium is achieved within -30 s after cartridge insertion. There are optical systems in the monitor to read a static bar code on the cartridge identifying the assay type and lot code and to illuminate the sample application site so that sample application can be detected. The monitor software has fail-safe features to enable recognition of system failures in either monitor or cartridge (including detection of a previously used or expired cartridge), environmental conditions that are outside the system .348 Table 1 A B C D operating range, user noncompliance with system prompts, insufficient sample volume, and sample hemolysis. When a condition is identified that would invalidate the results, an appropriate message is given. Additionally, if the sample hematocrit is higher than the clinically validated limits of the system (55%), no results are given.
Reagent cartridge.
Sample handling and assay reactions take place within the cartridge. The cartridge is a plastic housing (6.2 x 4.5 x 0.3 cm) made from two injection-molded pieces welded together (Figure 1 ). Surrounding the sample-application port on the upper surface of the front of the cartridge is a raised lip that collects and holds excess sample, protecting the monitor and users. Channels in the cartridge transport the sample by capillary action to assay-specific stacks. The stacks contain assay reagents and comprise contiguous layers of porous materials ifiling cylindrical cavities in the cartridge (Figure 2) . Sample in the stacks is either filtered to remove erythrocytes or lysed. Assay reagents dissolve in and react with the sample to form colored products in the uppermost layer of the stack, which is a flat, uniform, porous membrane and is the surface illuminated by the optics. An opening in the cartridge allows the optical membrane to be in direct contact with the atmosphere. Controls. Two controls with normal and low abnormal concentrations of the three analytes are available. Controls are made from whole blood and contain erythrocytes. The fail-safe features of the system, especially the ability to detect a ifiter failure or a hemolyzed sample, can be tested in addition to the regular assay functions by using these control materials.
QC cartridge. In a unit-use system, such as described here, QC testsuse up one cartridge and are relatively more expensive than QC tests in a typical laboratory system. We have developed a mechanical device to test monitor function without using an assay cartridge. The device is called a Quality Control Cartridge (QCC). It is accepted by the monitor as a normal cartridge and processed in the same way, testing all monitor selfdiagnostics. The system passes the QCC check if the results generated are within specified ranges. The QCC gives results corresponding to normal or abnormal concentrations of analyte depending on the position of the QCC switch.
Protocol and operating sequence. The user inserts a cartridge into the monitor, and all subsequent messages and results appear on a liquid-crystal display. The user is prompted to apply a drop of blood after the monitor has completed self-diagnostic checks, verified that the cartridge is not from an expired lot, examined the cartridge to see that the reflectance is within limits specified for each of the chemistry stacks, and brought the cartridge to operating temperature (37 #{176}C). If the user applies blood within a preset time after the applyblood prompt, the monitor allows the assay to proceed. Any volume >35 pL is sufficient, and no further user intervention is required or allowed before the result is displayed. In the glucose and cholesterol stacks, erythrocytes are removed by filtration before moving into a carrier membrane containing assay chemicals. In the hemoglobin stack, blood is drawn into a porous disk containing detergent and is lysed before moving into a membrane at the top of the stack. The monitor measures the reflectance at each stack at several wavelengths. Any unusual optical event (that would indicate a defective cartridge or hemolyzed sample) is noted and triggers a warning. The color produced in each assay is measured and converted by a simple algorithm (by using previously imported, lot-specific calibration parameters) to analyte concentration, which is displayed.
Materials
Analyte concentrations in clinical samples and control materials were determined by using the Kodak Monitors. Prototype monitors were used for the data reported here. These units were configured with all features of the final system, having printed circuit boards and molded cases. Data were collected via an RS232 port into computer spreadsheets that simulate the software functions of the monitor and permit realtime visual display.
Cartridges.
Prototype molded cartridges were made of acrylonitrile-butadiene-styrene. The cartridge consists of two molded pieces and stack components. All four stack cavities were ifiled with up to three different types of stacks. The ifiter in the glucose and cholesterol stacks is a nonwoven polypropylene felt (Ergon 5.7 ounces! square yard) impregnated with antibody to erythrocytes (1 g/L; Organon-Teknika, Rockville, MD) then dried. The filter stacks also contain a membrane and a mesh to control fluid movement. In all cases, at the top of the stack is a porous membrane that serves as the reflective member. In the glucoseand cholesterol stacks the assay reagent is incorporated into this membrane. The hemoglobin stack has detergent impregnated into a porous plastic disk. Stack configurations are given in Table 1 .
Before assembly, the plastic parts of the cartridge were subjected to plasma etching, which reduces the contact angle between blood and plastic and so promotes capillary flow in the cartridge. Cartridges were assembled after disks of each element were inserted into the upper part of the cartridge. The lower part of the cartridge was then welded to the upper to capture the stacks in the stack cavities and seal the capillary channels. Cartridges were individually packaged in aluminum and plastic foil with a desiccant pack.
Chemical reactions.
For glucose measurement we used glucose oxidase (Aspergillus niger, 1.4 U), horseradish peroxidase (0.28 U), 4 Assay protocols. After the cartridge was inserted into the monitor, blood samples (typically 35 L) were added, reactions were generally monitored for 3 mm, and reflectance values were recorded after 3 mm or after reflectance did not change with time. Reflectance was usually measured at 585 nm for all assays.
Calculations.
R was defined as the ratio of signal after completion of the reaction to that recorded before wetting of the stack. A simplified version of the KubelkaMunk (12) relationship, K/S = (1 -R)2!2R, was used to calculate KJS, where K is the absorption coefficient of the chromophore-membrane pair, a function of the absorbance and concentration of the chromophore, and S is the scattering coefficient of the membrane. For optically thick membranes, K/S is directly proportional to the concentration of colored product. K/S values were converted to analyte concentrations with a calibration function (usually a four-term polynomial) derived from data from at least five calibration materials spanning the assay range.
Results

Optics
The optical system is novel and its performance was evaluated to ensure that the system would give results comparable with established reflectance methods. A linear response was obtained over the range 5-90% reflectance (Figure 3 ) for all wavelengths. Essentially identical responses were found in the three optical channels tested, showing that the optics performance for different stack sites is not significantly different. The precision of the response at all wavelengths was excellent (<0.2% CV, which corresponds to <1% imprecision in analyte concentration over the clinical ranges) both 
Cartridge Performance
We found good reproducibility of flow time from sample application site to stack and time to saturate the assay stack. The time from sample application to completion of the wetting of the optical surface ranged from 45 to 90 a for blood of 0.20 to 0.60 hematocrit, respectively.
The efficiency of the erythrocyte filter was evaluated in glucose assay stacks by omitting assay reagent and measuring the color of the optical membrane at 585 nm, which corresponds to a major absorbance of hemoglobin. Any leaked erythrocytea or hemolysis would be detected in this way. Less than 1% leakage or hemolysis was found. The filter works by agglutination of the erythrocytes and depth filtration of the agglutinated cells in the fibrous mesh of the filter. The filter is effective for blood with hematocrit up to 0.60. Dissolution and mixing of reagents and sample occurs spontaneously as the sample fluid moves into the reagent-impregnated porous medium.
Selection of the reflective membrane and the chromophore generated by the chemical reaction is important in achieving optimum assay performance. Ideally, the optical membrane will not have a change in reflectance when its physical thickness is increased in the range of reflectance values relevant to the assays, and any colored material (such as erythrocytes) behind the membrane will have no optical effect. For each assay, the color yield corresponding to the assay quantitation range was determined both theoretically and experimentally. Yields were -80% for the glucose and cholesterol assays and 100% for hemoglobin. The chemical reactions selected use high concentrations of enzymes and excess enzyme substrates for rapid and complete conversion of analyte to the measured reaction product.
A typical assay progress curve is shown in Figure 4 . About 20s after sample application, reflectance begins to decline. Before this (during phase a in Figure 4 ) the monitor determines stack reflectance and compares it with preestablished norms to verify that the cartridge is not defective. There is a rapid decline in reflectance as the optical membrane becomes wet. This is due to the increase in refractive index of medium impregnating the membrane pores (air being replaced by plasma). This change causes reduction of the specific reflectance (S) of the membrane (phase b).
The reagents dissolve rapidly in the plasma and react with the analyte.
Within 2-3 mm, the reaction is complete, as shown by the lack of change of reflectance (phase c). Independent measurements showed that 80% conversion occursin all the assaysover the entire analyte range. Assays in which there is complete conversion to colored product and where the reflective matrix is optically thick should have a linear response of K/S to analyte, which is the case for all three assays reported here, as exemplified by the response of the glucose assay ( Figure 5 ). The response is essentially linear up to the highest analyte concentrations. At high analyte concentrations, the response declines somewhat because of incomplete conversion. Such nonlinearity is, of course, easily dealt with by appropriate calibration.
After calibration, all assays gave results that correlate well with established methods. As shown in Figure  6 , the glucose assay correlates excellently with a commercially available method (regression line slope is 1.0 and intercept is negligibly small). Correlation statistics for all the assays are presented in Table 2 . For these correlation studies it was convenient to use heparinized venous blood samples. To compare finger-stick and ye- 
DIscussIon
Technology that is well suited to patient-side testing has only recently become available for a few specific analytes (2, 5, 7-9, 13). Future developments will be determined by the speed, reliability, and convenience with which results can be obtained and, more importantly, by the relevance of the assaysto clinical practice.
The system described here addressessituations where several assay results are necessary or useful in a physician's office. The choice and number of analytes is a key issue. It is possiblethat a patient-side system would produce the same complete set of results available from clinical laboratories. We have selected a strategy that provides fewer analytical results in carefully selected sets appropriate to specific situations.
In general, the cost and unreliability of any system rises with the number of analytes. The approach presented here attempts to minimi7e the number of assays run at one time. The first set of analytes we chose-glucose, cholesterol, and hemoglobin-could be called a wellness panel and was selected to determine the overall health of patients with respect to the most common undiagnosed disorders. We plan to have a lipid panel comprising total cholesterol, high-density-lipoprotein cholesterol, and triglycerides, which will examine lipid metabolism to assessrisk factors for heart disease and atherosclerosis. Obviously there are several other analyte sets that would serve the needs of other specific medical situations.
The present system has a simple protocol suitable for patient-side use and has fail-safe features that improve the reliability of the results. Our intent was to remove as much of the responsibility as possible from the user for obtaining a valid set of results. Although the user can fail to get a result if the system instructions are not followed, incorrect results will not be given. The protocol is designed to be as forgiving as possible to the inevitable variability of user practices. The performance of the system at this stage of development is consistent with product specifications for existing laboratory methods. 
